The EBMT activity survey: 1990-2010 (Q28265604)

5

0 references

Jakob R. Passweg

object named as

J R Passweg

1

1 reference

ORCID Public Data File 2021

Christina Peters

12

object named as

C Peters

0 references

author name string

H Baldomero

2

0 references

A Gratwohl

3

0 references

M Bregni

4

0 references

P Dreger

6

0 references

T de Witte

7

0 references

D Farge-Bancel

8

0 references

B Gaspar

9

0 references

M Mohty

11

0 references

A Tichelli

13

0 references

A Velardi

14

0 references

C Ruiz de Elvira

15

0 references

F Falkenburg

16

0 references

A Sureda

17

0 references

J Marsh

Bone Marrow Transplantation

10

0 references

language of work or name

English

0 references

publication date

July 2012

0 references

published in

0 references

volume

47

0 references

issue

7

0 references

page(s)

906-23

0 references

cites work

Hematopoietic stem cell transplantation: a global perspective

1 reference

https://api.crossref.org/works/10.1038/BMT.2012.66

Defining the intensity of conditioning regimens: working definitions

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/BMT.2012.66

Hematopoietic stem-cell transplantation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Hematopoietic-cell transplantation at 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

The EBMT activity survey 2008: impact of team size, team density and new trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Predictability of hematopoietic stem cell transplantation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

The survey on cellular and engineered tissue therapies in Europe in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Bone marrow transplantation for inherited bone marrow failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Hematopoietic SCT activity in Asia: a report from the Asia-Pacific Blood and Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

inferred from DOI database lookup

7 January 2021

based on heuristic

The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66

inferred from DOI database lookup

7 January 2021

based on heuristic

The role of allogeneic-cell transplantation in leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.66